POSB244 Regional Variation in Uptake of Recommended Cancer Treatments in England (2018-2020) - An Osimertinib Case Study

Abstract

Authors

O Watkins AL Lewis M Franceschini CA Jones

Full Text Cite This Article
Back to ISPOR Europe 2021 Abstracts: Emerging Frontiers and Opportunities
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×